Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (Weighted Average) (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Shares Outstanding (Weighted Average) of $25.7 million for Q4 2025, up 1566.97% on a QoQ basis from $1.5 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Shares Outstanding (Weighted Average) data on file, last reported at $25.7 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed N/A year-over-year to $25.7 million; the trailing twelve-month figure through Oct 2025 stood at $25.7 million (changed N/A YoY), and the FY2025 full-year result was $1.5 million, down 91.17% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $25.7 million, up from $1.5 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $25.7 million in Q4 2025 and bottomed at $1.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | 25.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 25.73 Mn |
| Apr 30, 2025 | 1.54 Mn |
| Apr 30, 2024 | 17.48 Mn |